BNP Paribas Financial Markets’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$48.7M Sell
1,706,196
-287,434
-14% -$6.19M 0.02% 782
2026
Q1
$22.9M Buy
1,993,630
+1,264,710
+174% +$17.8M 0.01% 1063
2025
Q4
$10.5M Buy
728,920
+663,659
+1,017% +$11.5M ﹤0.01% 1579
2025
Q3
$1.24M Buy
65,261
+39,110
+150% +$645K ﹤0.01% 2981
2025
Q2
$561K Buy
26,151
+7,804
+43% +$116K ﹤0.01% 3259
2025
Q1
$241K Sell
18,347
-25,526
-58% -$379K ﹤0.01% 3601
2024
Q4
$590K Buy
+43,873
New +$706K ﹤0.01% 3183
2022
Q4
– Sell
-96,705
Closed -$483K – 4441
2022
Q3
$483K Buy
+96,705
New +$564K ﹤0.01% 3012

Other funds holding OSCR

BNP Paribas Financial Markets's OSCR Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Oscar Health (OSCR) stake by 14% in Q2 2026, selling an estimated $6.19M and leaving 1,706,196 shares worth $48.7M. The position accounts for 0.02% of the portfolio, ranked #782.

BNP Paribas Financial Markets first reported a position in OSCR in Q3 2022 and has held it in 8 quarters since. 404 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • BNP Paribas Financial Markets held 1,706,196 shares of Oscar Health worth $48.7M as of Q2 2026.
  • BNP Paribas Financial Markets sold 287,434 Oscar Health shares in Q2 2026, an estimated $6.19M.
  • Oscar Health made up 0.02% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #782 holding.
  • BNP Paribas Financial Markets first reported a position in Oscar Health in Q3 2022 and has held it in 8 quarters since.
  • 404 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.